ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,254.18
-0.76%
Dow Jones
38,801.48
-0.69%
Gold vs US Dollar
2,357.465
0.24%
Brent Oil
83.84
1.20%
Bitcoin
67,843.31
-2.23%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Zosano Pharma Corporation (ZSAN)

  7. Zosano Pharma Corporation (ZSAN) News

Zosano Pharma (ZSAN)

Zosano Pharma Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ZSAN
DateTimeSourceHeadlineSymbolCompany
19/07/202216:48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:ZSANZosano Pharma Corporation
08/06/202200:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZSANZosano Pharma Corporation
08/06/202200:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ZSANZosano Pharma Corporation
02/06/202213:36Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
02/06/202213:00GlobeNewswire Inc.Zosano Pharma Files Voluntary Petition for Relief Under Chapter 11NASDAQ:ZSANZosano Pharma Corporation
18/05/202213:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
13/05/202221:17Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ZSANZosano Pharma Corporation
13/05/202221:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
13/05/202221:00GlobeNewswire Inc.Zosano Pharma Reports First Quarter 2022 Financial ResultsNASDAQ:ZSANZosano Pharma Corporation
05/05/202222:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
29/04/202221:02Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ZSANZosano Pharma Corporation
29/04/202221:00GlobeNewswire Inc.Zosano Pharma Provides Corporate UpdateNASDAQ:ZSANZosano Pharma Corporation
11/04/202213:00GlobeNewswire Inc.Zosano Pharma Announces Reverse Stock Split Effective TodayNASDAQ:ZSANZosano Pharma Corporation
01/04/202221:22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:ZSANZosano Pharma Corporation
22/03/202211:46TipRanksMaxim Group Thinks Zosano Pharma’s Stock is Going to RecoverNASDAQ:ZSANZosano Pharma Corporation
17/03/202220:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
17/03/202220:05GlobeNewswire Inc.Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial ResultsNASDAQ:ZSANZosano Pharma Corporation
14/02/202211:19Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ZSANZosano Pharma Corporation
11/02/202222:31Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ZSANZosano Pharma Corporation
09/02/202222:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
09/02/202222:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ZSANZosano Pharma Corporation
09/02/202202:55GlobeNewswire Inc.Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and WarrantsNASDAQ:ZSANZosano Pharma Corporation
08/02/202221:18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ZSANZosano Pharma Corporation
08/02/202221:10GlobeNewswire Inc.Zosano Pharma Announces Proposed Public Offering of Common Stock and WarrantsNASDAQ:ZSANZosano Pharma Corporation
24/01/202213:20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
05/01/202217:01GlobeNewswire Inc.CORRECTION - Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher DoseNASDAQ:ZSANZosano Pharma Corporation
05/01/202214:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
05/01/202214:20GlobeNewswire Inc.Zosano Pharma Announces Publication of Clinical Data Demonstrating Comparable Immunogenicity of a Trivalent Influenza Vaccine Formulated on its Transdermal Microneedle System Versus an Intramuscular Injection of the Vaccine at a Higher DoseNASDAQ:ZSANZosano Pharma Corporation
13/12/202121:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ZSANZosano Pharma Corporation
13/12/202121:30GlobeNewswire Inc.Zosano Pharma Announces Changes to Board of Directors; Appoints Cross Functional Business Executive Elaine M. YangNASDAQ:ZSANZosano Pharma Corporation
 Showing the most relevant articles for your search:NASDAQ:ZSAN

Your Recent History

LSE
POS
Plexus
LSE
RR.
Rolls-royce
LSE
QED
Quadrise
LSE
BP.
Bp
LSE
INSP
Inspirit Energy
LSE
ITV
Itv
LSE
NG.
National Grid
LSE
VAST
Vast Resources
LSE
ZED
Zenova
LSE
BOO
Boohoo
LSE
MIN
Minoan
LSE
SAR
Sareum
LSE
TERN
Tern
LSE
GPL
Graft Polymer (uk)
LSE
EME
Empyrean Energy
LSE
PANR
Pantheon Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved